Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1992 Oct;68(5):312–316. doi: 10.1136/sti.68.5.312

Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.

G R Kinghorn 1, P D Woolley 1, R N Thin 1, J De Maubeuge 1, J M Foidart 1, R Engst 1
PMCID: PMC1195986  PMID: 1385295

Abstract

OBJECTIVE--To compare the efficacy and safety of oral acyclovir (400 mg twice daily) with oral isoprinosine (500 mg twice daily) in the suppression of recurrent genital herpes. DESIGN--Double-blind, double-dummy, randomised, controlled, parallel group trial. SETTING--13 centres in UK, Belgium and Germany. SUBJECTS--127 immunocompetent patients with frequently recurring genital herpes. MAIN OUTCOME MEASURES--Proportions of patients reporting recurrences, recurrence frequency, and mean duration of lesions during breakthrough recurrences in each treatment group during a 6 month treatment period; time to first recurrence during treatment and follow-up after treatment cessation. RESULTS--During treatment, acyclovir recipients showed significant differences (p < 0.05) when compared with isoprinosine recipients in terms of a lower proportion reporting recurrences (31% vs 96%), a reduced mean number of reported recurrences per patient (0.6 vs 3.6), a shorter mean duration of breakthrough lesions (6.4 days vs 8.2 days), and a longer mean time (standard error) to first recurrence (143.7 (9.1) days vs 40.5 (5.4) days. The mean time to first recurrence after treatment cessation did not differ between the two groups. As compared with placebo recipients, isoprinosine treated patients had an increased recurrence frequency (3.6 vs 2.5) during treatment, and a shorter time to first recurrence after treatment cessation. All treatments were well tolerated without serious adverse events or toxicity. CONCLUSIONS--Acyclovir is very effective in suppressing recurrent genital herpes and is clearly superior to isoprinosine which is not clinically useful in the dosage studied.

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belsey E. M., Adler M. W. Current approaches to the diagnosis of herpes genitalis. Br J Vener Dis. 1978 Apr;54(2):115–120. doi: 10.1136/sti.54.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fiddian A. P., Kinghorn G. R., Goldmeier D., Rees E., Rodin P., Thin R. N., de Konig G. A. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. J Antimicrob Chemother. 1983 Sep;12 (Suppl B):67–77. doi: 10.1093/jac/12.suppl_b.67. [DOI] [PubMed] [Google Scholar]
  3. Halsos A. M., Salo O. P., Lassus A., Tjøtta E. A., Hovi T., Gabrielsen B. O., Fiddian A. P. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study. Acta Derm Venereol. 1985;65(1):59–63. [PubMed] [Google Scholar]
  4. Kinghorn G. R., Jeavons M., Rowland M., Abeywickreme I., Barton I. G., Potter C. W., Hickmott E. A. Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study. Genitourin Med. 1985 Dec;61(6):387–390. doi: 10.1136/sti.61.6.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kinghorn G. R. Topical acyclovir in the treatment of recurrent herpes simplex virus infections. Scand J Infect Dis Suppl. 1985;47:58–62. [PubMed] [Google Scholar]
  6. Mindel A., Carney O., Sonnex C., Freris M., Patou G., Williams P. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex. Genitourin Med. 1989 Apr;65(2):103–105. doi: 10.1136/sti.65.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mindel A., Faherty A., Carney O., Patou G., Freris M., Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet. 1988 Apr 23;1(8591):926–928. doi: 10.1016/s0140-6736(88)91725-4. [DOI] [PubMed] [Google Scholar]
  8. Mindel A., Weller I. V., Faherty A., Sutherland S., Hindley D., Fiddian A. P., Adler M. W. Prophylactic oral acyclovir in recurrent genital herpes. Lancet. 1984 Jul 14;2(8394):57–59. doi: 10.1016/s0140-6736(84)90237-x. [DOI] [PubMed] [Google Scholar]
  9. Nilsen A. E., Aasen T., Halsos A. M., Kinge B. R., Tjøtta E. A., Wikström K., Fiddian A. P. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982 Sep 11;2(8298):571–573. doi: 10.1016/s0140-6736(82)90658-4. [DOI] [PubMed] [Google Scholar]
  10. Reichman R. C., Badger G. J., Mertz G. J., Corey L., Richman D. D., Connor J. D., Redfield D., Savoia M. C., Oxman M. N., Bryson Y. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA. 1984 Apr 27;251(16):2103–2107. [PubMed] [Google Scholar]
  11. Straus S. E., Takiff H. E., Seidlin M., Bachrach S., Lininger L., DiGiovanna J. J., Western K. A., Smith H. A., Lehrman S. N., Creagh-Kirk T. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984 Jun 14;310(24):1545–1550. doi: 10.1056/NEJM198406143102401. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES